Drug: emend Quarter: 2016Q3
Total Drug/Injury Combinations: 233 Number of Pages: 12
DRUGNAME | PT | EventCount | |
---|---|---|---|
EMEND (FOSAPREPITANT DIMEGLUMINE) | Malignant neoplasm progression | 2 | view events |
EMEND (FOSAPREPITANT DIMEGLUMINE) | No adverse event | 2 | view events |
EMEND (FOSAPREPITANT DIMEGLUMINE) | Product use issue | 2 | view events |
EMEND | Abdominal pain | 1 | view events |
EMEND | Adverse reaction | 1 | view events |
EMEND | Amnesia | 1 | view events |
EMEND | Asthenopia | 1 | view events |
EMEND | Balance disorder | 1 | view events |
EMEND | Blood creatinine increased | 1 | view events |
EMEND | Blood lactic acid increased | 1 | view events |
EMEND | Blood pressure abnormal | 1 | view events |
EMEND | Blood pressure decreased | 1 | view events |
EMEND | Blood urine present | 1 | view events |
EMEND | Body temperature fluctuation | 1 | view events |
EMEND | Cardiac arrest | 1 | view events |
EMEND | Cardio-respiratory arrest | 1 | view events |
EMEND | Cerebrovascular accident | 1 | view events |
EMEND | Colon cancer | 1 | view events |
EMEND | Coma | 1 | view events |
EMEND | Dehydration | 1 | view events |
Total Drug/Injury Combinations: 233 Number of Pages: 12
NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)